fashion -WSS

fashion

author：comprehensive 2025-10-01 18:44:52 - browse：15

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Can medical device makers keep up in the race to treat obesity?

Listen: Your guide to Wegovy’s blockbuster heart study

WSS

Eli Lilly’s Mounjaro succeeds in second weight

Mom launches Girl Scout troop for LGBTQ youth in Texas

Novo: Oral version of Ozempic leads to 15% weight loss

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Pfizer's RSV vaccine recommended for approval in Europe

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Listen: Your guide to Wegovy’s blockbuster heart study

Virginia high school admissions case could be legal follow

What is artificial intelligence? Experts weigh in

Novavax promises a turnaround & Lilly roils the obesity market

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

At least 13 dead in Texas as scorching temps continue

What is the Turing Test that determines if computers can think?

Heart attack and stroke risk calculators need revising

The biotech scorecard for the 2nd quarter: 12 industry events to watch

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden White House, tech companies launch new safeguards around emerging AI technology

hotspot

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Inside the rise of 'mukbang' eating videos

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Reframing the conversation around gain

New chart reveals military’s vast involvement in Operation Warp Speed

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

knowledge

Wikipedia

Listen: Your guide to Wegovy’s blockbuster heart study

knowledge